Bayesian Capital Management LP Takes Position in Leidos Holdings, Inc. (NYSE:LDOS)

Bayesian Capital Management LP purchased a new position in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 21,972 shares of the aerospace company's stock, valued at approximately $3,165,000.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of Leidos in the fourth quarter worth $25,000. Duncker Streett & Co. Inc. acquired a new stake in Leidos during the 4th quarter worth about $27,000. Berbice Capital Management LLC acquired a new position in shares of Leidos in the 4th quarter valued at about $29,000. Mather Group LLC. raised its position in Leidos by 143.1% during the fourth quarter. Mather Group LLC. now owns 265 shares of the aerospace company's stock valued at $38,000 after acquiring an additional 156 shares in the last quarter. Finally, Human Investing LLC acquired a new stake in shares of Leidos during the 4th quarter worth approximately $52,000. 76.12% of the stock is currently owned by institutional investors and hedge funds.

Leidos Trading Down 0.0 %

NYSE LDOS traded down $0.07 on Wednesday, reaching $154.68. 1,612,037 shares of the company were exchanged, compared to its average volume of 1,205,976. The company has a current ratio of 1.21, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. Leidos Holdings, Inc. has a fifty-two week low of $123.62 and a fifty-two week high of $202.90. The business's fifty day moving average price is $138.68 and its 200 day moving average price is $149.59. The stock has a market capitalization of $19.83 billion, a P/E ratio of 16.74, a price-to-earnings-growth ratio of 1.65 and a beta of 0.65.

Leidos (NYSE:LDOS - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The aerospace company reported $2.97 EPS for the quarter, beating the consensus estimate of $2.47 by $0.50. The firm had revenue of $4.25 billion for the quarter, compared to analyst estimates of $4.11 billion. Leidos had a net margin of 7.53% and a return on equity of 30.93%. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.29 EPS. Analysts forecast that Leidos Holdings, Inc. will post 10.62 earnings per share for the current year.

Leidos Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a $0.40 dividend. The ex-dividend date is Monday, June 16th. This represents a $1.60 annualized dividend and a yield of 1.03%. Leidos's dividend payout ratio (DPR) is currently 17.32%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Wells Fargo & Company decreased their price objective on shares of Leidos from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Tuesday, April 8th. Cantor Fitzgerald raised Leidos to a "strong-buy" rating in a report on Tuesday, February 25th. StockNews.com downgraded Leidos from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, April 30th. Truist Financial dropped their price target on shares of Leidos from $165.00 to $155.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Finally, UBS Group upped their price objective on shares of Leidos from $149.00 to $168.00 and gave the stock a "neutral" rating in a research report on Wednesday. Five equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Leidos currently has a consensus rating of "Moderate Buy" and a consensus price target of $178.62.

Insiders Place Their Bets

In related news, Director Robert C. Kovarik, Jr. sold 1,511 shares of Leidos stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $134.56, for a total value of $203,320.16. Following the completion of the transaction, the director now owns 6,408 shares in the company, valued at approximately $862,260.48. The trade was a 19.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gary Stephen May sold 2,128 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $131.24, for a total value of $279,278.72. Following the sale, the director now directly owns 11,264 shares in the company, valued at $1,478,287.36. This represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.